Postprandial secretion of serotonin and melatonin in patients with functional dyspepsia

Clinical and Experimental Medical Letters

Volumn 50, Issue 3, 2009, Pages 165-168

  Wiśniewska Jarosińska, Maria ^a   Harasiuk, Agnieszka ^a   Walecka Kapica, Ewa ^a   Pawłowicz, Monika ^a   Stec Michalska, Krystyna ^a   Chojnacki, Jan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Epigastric pain syndrome; Functional dyspepsia; Melatonin; Postprandial distress syndrome; Serotonin

Indexed keywords

ANTIBODY; MELATONIN; MINERAL WATER; SEROTONIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIET; DIET RESTRICTION; DYSPEPSIA; ENZYME IMMUNOASSAY; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL DYSPEPSIA; HORMONE RELEASE; HUMAN; MALE; MEAL; POSTPRANDIAL STATE; SEROTONIN BLOOD LEVEL;

EID: 77953372602     PISSN: 18952089     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Racké K, Reimann A, Schwörer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73: 83-7.
2. Messner M, Huether G, Lorf T, Ramadori G, Schwörer H. Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci 2001; 69: 543-51.
3. Huether G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993; 49: 665-70.
4. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-48.
5. Huether G, Hajak G, Reimer A. The metabolic fate of infused L-tryptophan in men: pssible clinical implications of the accumulation of circulatory tryptophan and tryptophan metabolites. Psychopharmacol 1992; 106: 422-32.
6. Yaga H, Reiter RJ, Richardson BA. Tryptophan loading increases day-time serum melatonin in intact and pinealectomized rats. Life Sci 1993; 52: 1231-8.
7. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci 1994; 91: 1824-8.
8. Dawson D, Gibbon S, Singh P. The hypothermic effect of melatonin on core body temperature: is more better? J Pineal Res 1996; 20: 192-7.
9. Aizawa S, Tokura H, Morita T. The administration of exogenous melatonin during the daytime lowers the termoregulatory setpoint in humans. J Thermal Biol 2002; 27: 115-9.
10. Huether G. Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin. Ann N Y Acad Sci 1994; 719: 146-58.
11. Bubenik GA, Ball RO, Pang SF. The effect of food deprivation on brain and gastrointestinal tissue levels of tryptophan, serotonin, 5-hydroxyindoleacetic acid, and melatonin. J Pineal Res 1992; 12: 7-16.
12. Gershon MD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20(Suppl 7): 3-14.
13. Gaster LM, King FD. Serotonin 5-HT3 and 5-HT4 receptor antagonists. Med Res Rev 1997; 17: 163-214.
14. Kasimay O, Cakir B, Deverseren E, Yegen BC. Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol 2005; 56: 543-53.
15. Harlow HJ, Weekley BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res 1986; 3: 277-84.
16. Bubenik GA. The effect of serotonin, N-acetylserotonin, and melatonin on spontaneous contractions of isolated rat intestine. J Pineal Res 1986; 3: 41-54.
17. Mertz H. Review article: visceral hypersensitivity. Aliment Pharmacol Ther 2003; 17: 623-33.
18. Gebhart GF. Physiology, pathophysiology and pharmacology of visceral pain. Reg Anesth Pain Med 2000; 25: 632-8.
19. Drossman DA. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol 2004 ; 2: 353-65.
20. Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1402-7.
21. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005; 22: 927-34.
22. Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol 2007; 41: 29-31.
23. Konturek PC, Konturek SJ, Brzozowski T, Dembinski A, Zembala M, Mytar B et al. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32: 433-8.
24. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Bandyopadhyay D. Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. J Physiol Pharmacol 2003; 54(Suppl 4): 113-25.
25. Sjöblom M, Flemström G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34: 288-93.
26. Klupińska G, Harasiuk A, Chojnacki C, Jajte J, Stȩpień A, Stec-Michalska K, et al. Nocturnal secretion of melatonin in patients with duodenal ulcer disease and ulcer-like dyspepsia. Adv Clin Exp Med 2006; 15: 575-80.
27. Klupińska G, Harasiuk A, Popławski T, Chojnacki C, Błasaiak J, Chojnacki J. Nocturnal secretion of melatonin in patients with functional dyspepsia. Gastroenterol Pol 2007; 14: 103-6.
28. Klupińska G, Wiśniewska-Jarosińska M, Harasiuk A, Chojnacki C, Stec-Michalska K, Błasiak J, et al. J. Nocturnal secretion of melatonin in patients with upper digestive tract disorders. J Physiol Pharmacol 2006; 57(Suppl. 5): 41-50.